Page 103 - 《中国药房》2025年5期

[ 4 ] KIM Y S，YUN H J，SHIM S K，et al. A comparative trial Pharmaceutical Association Hospital Pharmacy Profes‐
of a single dose of azithromycin versus doxycycline for sional Committee，Infectious Diseases Professional Com‐
the treatment of mild scrub typhus[J]. Clin Infect Dis， mittee of China Medical Education Association. Expert
2004，39（9）：1329-1335. consensus on antimicrobial dosing optimization during
[ 5 ] PHIMDA K，HOONTRAKUL S，SUTTINONT C，et al. continuous renal replacement therapy：2024 edition[J].
Doxycycline versus azithromycin for treatment of leptospi- Chin J Nephrol，2024，40（2）：158-174.
rosis and scrub typhus[J]. Antimicrob Agents Chemother， [13] 中国医师协会呼吸医师分会危重症医学专业委员会，中
2007，51（9）：3259-3263. 华医学会呼吸病学分会危重症医学学组. 体外膜式氧合
[ 6 ] KABIR K I，JOHN J，SATAPATHY A K，et al. Oral 治疗成人重症呼吸衰竭推荐意见[J]. 中华结核和呼吸杂
azithromycin versus doxycycline in the treatment of chil‐ 志，2019，42 （9）：660-684.
dren with uncomplicated scrub typhus：a randomized con‐ The Critical Care Medicine Professional Committee of the
trolled trial[J]. Pediatr Infect Dis J，2022，41（3）：224-229. Respiratory Physicians Branch of the Chinese Medical
[ 7 ] 临床常用四环素类药物合理应用多学科专家共识编写 Association，Critical Care Medicine Group，Respiratory
组，中华预防医学会医院感染控制分会，中国药理学会 Medicine Branch，Chinese Medical Association. Recom‐
临床药理分会. 临床常用四环素类药物合理应用多学科 mendations for the use of extracorporeal membrane oxy‐
专家共识[J]. 中华医学杂志，2023，103（30）：2281-2296. genation in adult patients with severe respiratory failure
Editing Group for Multidisciplinary Expert Consensus on [J]. Chin J Tuberc Respir Dis，2019，42（9）：660-684.
the Rational Use of Tetracyclines Commonly Used in [14] 张玉，陈孝，张毕奎，等. 新型冠状病毒肺炎临床合理用
Clinical Practice，Hospital Infection Control Branch of 药 专 家 共 识 [J]. 中 国 医 院 药 学 杂 志 ，2020，40（6）：
Chinese Preventive Medicine Association，Clinical Phar‐ 593-605.
macology Branch of Chinese Pharmacological Society. ZHANG Y，CHEN X，ZHANG B K，et al. Expert consen‐
Multidisciplinary expert consensus on the rational use of sus on rational drug use in clinical practice for COVID-19
tetracyclines commonly used in clinical practice[J]. Natl [J]. Chin J Hosp Pharm，2020，40（6）：593-605.
Med J China，2023，103（30）：2281-2296. [15] JARURATANASIRIKUL S， THENGYAI S，
[ 8 ] QUADE B R，RAMÍREZ-HERNÁNDEZ A，BLANTON WONGPOOWARAK W，et al. Population pharmacoki‐
L S. In vitro susceptibility of Rickettsia species to eravacy‐ netics and Monte Carlo dosing simulations of meropenem
cline， omadacycline， and tigecycline[J]. Antimicrob during the early phase of severe sepsis and septic shock in
Agents Chemother，2021，65（8）：e0066521. critically ill patients in intensive care units[J]. Antimicrob
[ 9 ] WATKINS R R，DERESINSKI S. Omadacycline：a novel Agents Chemother，2015，59（6）：2995-3001.
tetracycline derivative with oral and intravenous formula‐ [16] LERTWATTANACHAI T， MONTAKANTIKUL P，
tions[J]. Clin Infect Dis，2019，69（5）：890-896. TANGSUJARITVIJIT V，et al. Clinical outcomes of em‐
[10] LEE S M，KWON H Y，IM J H，et al. In vitro activity of pirical high-dose meropenem in critically ill patients with
tigecycline against Orientia tsutsugamushi[J]. Yonsei Med sepsis and septic shock：a randomized controlled trial[J]. J
J，2016，57（4）：1034-1037. Intensive Care，2020，8：26.
[11] VARGHESE G M，DAYANAND D，GUNASEKARAN [17] VEINSTEIN A，DEBOUVERIE O，GRÉGOIRE N，et al.
K，et al. Intravenous doxycycline，azithromycin，or both Lack of effect of extracorporeal membrane oxygenation
for severe scrub typhus[J]. N Engl J Med，2023，388（9）： on tigecycline pharmacokinetics[J]. J Antimicrob Che‐
792-803. mother，2012，67（4）：1047-1048.
[12] 连续性肾替代治疗抗菌药物剂量调整共识专家组，中国 [18] HAHN J，CHOI J H，CHANG M J. Pharmacokinetic
药学会医院药学专业委员会，中国医药教育协会感染疾 changes of antibiotic，antiviral，antituberculosis and anti‐
病专业委员会. 连续性肾替代治疗抗菌药物剂量调整专 fungal agents during extracorporeal membrane oxyge-
家共识：2024 年版[J]. 中华肾脏病杂志，2024，40（2）： nation in critically ill adult patients[J]. J Clin Pharm Ther，
158-174. 2017，42（6）：661-671.
Expert Group of Antimicrobial Dosing Optimization Du- （收稿日期：2024-12-02 修回日期：2025-02-07）
ring Continuous Renal Replacement Therapy，Chinese （编辑：林 静）

中国药房 2025年第36卷第5期 China Pharmacy 2025 Vol. 36 No. 5 · 605 ·